Global Thyroid Gland Disorder Treatment Market - Analysis, Technologies & Forecasts to 2021 - Increasing Demand for Levothyroxine & Rising Focus on Emerging Economies - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Thyroid Gland Disorder Treatment Market 2017-2021" report to their offering.

The global thyroid gland disorder treatment market to grow at a CAGR of 3.24% during the period 2017-2021.

The report, Global Oscilloscope Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Globally, the thyroid gland disorder treatment market is expected to grow at a high growth rate owing to the rising prevalence of thyroid gland disorders. The market has witnessed a growing preference for thyroid therapeutics in developed as well as developing regions. The vendors are focusing on the untapped emerging economies such as the Middle East, Africa, China, and India.

According to the report, globally, 750 million people suffer from thyroid disorders, among which more than half are undiagnosed. The AACE has initiated a campaign to increase public awareness about thyroid disorders and educate the Americans regarding the treatment. These camps were to educate people about increased risk for developing a thyroid disorder, the prevalence of the disease, and focus on educating and preventing programs. Globally, every year, the International Thyroid Awareness Week is celebrated in the month of November.

Key vendors

  • AbbVie
  • Pfizer
  • Merck Sharp & Dohme

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by type

PART 07: Geographical segmentation

PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market Challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

PART 14: Key vendor analysis

For more information about this report visit http://www.researchandmarkets.com/research/39skbl/global_thyroid

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Endocrine and Metabolic Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Endocrine and Metabolic Disorders Drugs